89 related articles for article (PubMed ID: 2671679)
1. c-myc oncogene expression and clinical outcome in carcinoma of the cervix.
Sowani A; Ong G; Dische S; Quinn C; White J; Soutter P; Waxman J; Sikora K
Mol Cell Probes; 1989 Jun; 3(2):117-23. PubMed ID: 2671679
[TBL] [Abstract][Full Text] [Related]
2. C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study.
Vijayalakshmi N; Selvaluxmi G; Mahji U; Rajkumar T
Eur J Gynaecol Oncol; 2002; 23(2):135-8. PubMed ID: 12013111
[TBL] [Abstract][Full Text] [Related]
3. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
4. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
[TBL] [Abstract][Full Text] [Related]
5. Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.
Polacarz SV; Darne J; Sheridan EG; Ginsberg R; Sharp F
J Clin Pathol; 1991 Nov; 44(11):896-9. PubMed ID: 1752978
[TBL] [Abstract][Full Text] [Related]
6. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
7. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
8. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
O'Leary JJ; Landers RJ; Crowley M; Healy I; Kealy WF; Hogan J; Doyle CT
J Clin Pathol; 1997 Nov; 50(11):896-903. PubMed ID: 9462237
[TBL] [Abstract][Full Text] [Related]
9. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix.
Bourhis J; Le MG; Barrois M; Gerbaulet A; Jeannel D; Duvillard P; Le Doussal V; Chassagne D; Riou G
J Clin Oncol; 1990 Nov; 8(11):1789-96. PubMed ID: 2230867
[TBL] [Abstract][Full Text] [Related]
11. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
Riou GF; Bourhis J; Le MG
Anticancer Res; 1990; 10(5A):1225-31. PubMed ID: 2173473
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
Hendy-Ibbs P; Cox H; Evan GI; Watson JV
Br J Cancer; 1987 Mar; 55(3):275-82. PubMed ID: 3552016
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
[TBL] [Abstract][Full Text] [Related]
14. c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma.
Brenna SM; Zeferino LC; Pinto GA; Souza RA; Andrade LA; Vassalo J; Martinez EZ; Syrjanen KJ
Braz J Med Biol Res; 2002 Apr; 35(4):425-30. PubMed ID: 11960190
[TBL] [Abstract][Full Text] [Related]
15. [The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator].
Wu HJ
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):515-21. PubMed ID: 8754393
[TBL] [Abstract][Full Text] [Related]
16. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract][Full Text] [Related]
17. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix.
Symonds RP; Habeshaw T; Paul J; Kerr DJ; Darling A; Burnett RA; Sotsiou F; Linardopoulos S; Spandidos DA
Eur J Cancer; 1992; 28A(10):1615-7. PubMed ID: 1389474
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines.
Choo KB; Chong KY; Chou HF; Liew LN; Liou CC
Biochem Biophys Res Commun; 1989 Jan; 158(1):334-40. PubMed ID: 2463837
[TBL] [Abstract][Full Text] [Related]
19. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
[TBL] [Abstract][Full Text] [Related]
20. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix.
Pinion SB; Kennedy JH; Miller RW; MacLean AB
Lancet; 1991 Apr; 337(8745):819-20. PubMed ID: 1672915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
